xmlui.themes.about.link
Instituto de Investigación Marqués de Valdecilla (IDIVAL): Envíos recientes
Mostrando ítems 161-180 de 965
-
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
(Wiley-Blackwell, 2024) -
SEOM-GEMCAD-TTD clinical guidelines for the management of hepatocarcinoma patients (2023)
(Springer-Verlag Italia, 2024) -
Health education intervention for patients undergoing placement of percutaneous nephrostomy tube: a randomized controlled trial
(Wolters Kluwer Health, 2021) -
A hybrid trans-modal liquid crystal optical vortex generator
(Elsevier, 2025-02) -
Osteopontin as a biomarker in interstitial lung diseases
(MDPI AG, 2024-05-16) -
Lung transplantation for emphysema: only emphysema or something else?
(Pioneer Bioscience Publishing Company, 2023) -
SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis
(Nature Publishing Group, 2024) -
Discovery of a novel inhibitor of macropinocytosis with antiviral activity
(Academic Press/Cell Press, 2024) -
Brave new world: expanding home care in stem cell transplantation and advanced therapies with new technologies
(Frontiers Research Foundation, 2024) -
Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells
(Nature Publishing Group, 2024)







